ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding ProQR Therapeutics N.V. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 65 | 69 | +4 |
| Shares | 37.2M | 35.1M | −2.07M (−5.6%) |
| Value | $75.1M | $56.8M | −$18.2M (−24.3%) |
New holders (10)
Institutions that held ProQR Therapeutics N.V. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 115,945 | $187.8K | 0.00% |
| Gsa Capital Partners LLP | 114,256 | $185.0K | 0.01% |
| Graham Capital Management, L.P. | 91,553 | $148.3K | 0.01% |
| Axiom Investment Management LLC | 33,000 | $53.5K | 0.04% |
| Squarepoint Ops LLC | 31,518 | $51.1K | 0.00% |
| Nine Masts Capital Ltd | 29,518 | $47.8K | 0.01% |
| China Universal Asset Management Co., Ltd. | 20,000 | $32.4K | 0.00% |
| Susquehanna International Group, LLP | 12,206 | $19.8K | 0.00% |
| Hilton Head Capital Partners, LLC | 1,404 | $2.27K | 0.00% |
| Caitong International Asset Management Co., Ltd | 123 | $199 | 0.00% |
Sold out (6)
Institutions that held ProQR Therapeutics N.V. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| ArrowMark Colorado Holdings LLC | 1,164,722 | $2.35M |
| Two Sigma Advisers, LP | 452,400 | $913.8K |
| Fifth Third Bancorp | 30,000 | $60.6K |
| The PNC Financial Services Group, Inc. | 20,097 | $40.6K |
| Tower Research Capital LLC (TRC) | 1,211 | $2.45K |
| Rockefeller Capital Management L.P. | 34 | $69 |